E-LIB Suche - Ergebnisse für: Sadowsky, Carl H.

1

Pre‐pivotal clinical study of β‐amyloid in the ocular lens ..:

Goldstein, Lee E. ; Wilke, Susanne ; Goodman, Ira J...
Alzheimer's & Dementia. 17 (2021) S5 - p. , 2021

Link: https://doi.org/10.1002/..

2

P2‐245: A PRE‐PIVOTAL STUDY: B‐AMYLOID PLAQUE DETECTION IN ..:

Sadowsky, Carl H. ; Vlock, Daniel R. ; Villena, Tersea...
Alzheimer's & Dementia. 15 (2019) 7S_Part_13 - p. , 2019

Link: https://doi.org/10.1016/..

3

P4‐197: CLINICAL BENEFITS OF ORAL TRAMIPROSATE IN APOE4/4 H..:

Abushakra, Susan ; Porsteinsson, Anton P. ; Sadowsky, Carl H.
Alzheimer's & Dementia. 14 (2018) 7S_Part_29 - p. , 2018

Link: https://doi.org/10.1016/..

4

P3‐269: PROGNOSTIC VALUE OF EVENT‐RELATED POTENTIALS FOR RA..:

Cecchi, Marco ; Sadowsky, Carl H. ; Michalczuk, Diana.
Alzheimer's & Dementia. 14 (2018) 7S_Part_22 - p. , 2018

Link: https://doi.org/10.1016/..

5

Effectiveness of Florbetapir PET Imaging in Changing Patien..:

Pontecorvo, Michael J. ; Siderowf, Andrew ; Dubois, Bruno...
Dementia and Geriatric Cognitive Disorders. 44 (2017) 3-4 - p. 129-143 , 2017

Link: https://doi.org/10.1159/..

6

[P1–052]: CLINICAL EFFECTS OF TRAMIPROSATE IN APOE4 HOMOZYG..:

Abushakra, Susan ; Sadowsky, Carl H. ; Porsteinsson, Anton P....
Alzheimer's & Dementia. 13 (2017) 7S_Part_5 - p. , 2017

Link: https://doi.org/10.1016/..

7

Performance of [18F]flutemetamol amyloid imaging against th..:

Salloway, Stephen ; Gamez, Jose E. ; Singh, Upinder...
Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring. 9 (2017) 1 - p. 25-34 , 2017

Link: https://doi.org/10.1016/..

8

A clinical trial to validate event‐related potential marker..:

Cecchi, Marco ; Moore, Dennis K. ; Sadowsky, Carl H....
Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring. 1 (2015) 4 - p. 387-394 , 2015

Link: https://doi.org/10.1016/..

9

P2‐080: Neuropsychological correlates of erp cognitive meas..:

Cecchi, Marco ; Moore, Dennis ; Sadowsky, Carl H....
Alzheimer's & Dementia. 11 (2015) 7S_Part_11 - p. , 2015

Link: https://doi.org/10.1016/..

10

DT‐02‐03: A randomized, controlled, multicenter, internatio..:

Pontecorvo, Michael J. ; Siderowf, Andew ; Grundman, Michael...
Alzheimer's & Dementia. 11 (2015) 7S_Part_7 - p. , 2015

Link: https://doi.org/10.1016/..

11

Evaluating Response to High‐Dose 13.3 mg/24 h Rivastigmine ..:

Farlow, Martin R. ; Sadowsky, Carl H. ; Velting, Drew M...
CNS Neuroscience & Therapeutics. 21 (2015) 6 - p. 513-519 , 2015

Link: https://doi.org/10.1111/..

12

Detection of Amyloid β Signature in the Lens and Its Correl..:

Kerbage, Charles ; Sadowsky, Carl H. ; Tariot, Pierre N....
American Journal of Alzheimer's Disease & Other Dementiasr. 30 (2014) 8 - p. 738-745 , 2014

Link: https://doi.org/10.1177/..

13

Neuropathologic Heterogeneity Does Not Impair Florbetapir-P..:

Dugger, Brittany N. ; Clark, Christopher M. ; Serrano, Geidy...
Journal of Neuropathology & Experimental Neurology. 73 (2014) 1 - p. 72-80 , 2014

Link: https://doi.org/10.1097/..

14

Florbetapir (F18‐AV‐45) PET to assess amyloid burden in Alz..:

Johnson, Keith A. ; Sperling, Reisa A. ; Gidicsin, Christopher M....
Alzheimer's & Dementia. 9 (2013) 5S - p. , 2013

Link: https://doi.org/10.1016/..

15

The S-Connect study: results from a randomized, controlled ..:

Shah, Raj C ; Kamphuis, Patrick J ; Leurgans, Sue...
Alzheimer's Research & Therapy. 5 (2013) 6 - p. 59 , 2013

Link: https://doi.org/10.1186/..